LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Aandelen Lijst・Medtronic PLC

Search

Medtronic PLC

Gesloten

SectorGezondheidszorg

78.65 0.83

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

78.61

Max

78.91

Belangrijke statistieken
By Trading Economics
Inkomsten	-231M 1.1B
Verkoop	57M 9B
K/W Sectorgemiddelde	21.598 49.701
EPS	0.89
Dividendrendement	3.72
Winstmarge	12.675
Werknemers	95,000
EBITDA	124M 2.5B

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+33.44% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	3.72% 2.39%
Volgende Winsten	3 jun 2026
Volgende dividenddatum	10 jul 2026
Volgende Ex Dividend datum	26 jun 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-28B 99B
Vorige openingsprijs	77.82
Vorige sluitingsprijs	78.65

Nieuwssentiment

By Acuity

29%

71%

60 / 345 Rangschikking in Healthcare

Medtronic PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 mei 2026, 13:49 UTC

Acquisities, Fusies, Overnames

Medtronic to Buy SPR Therapeutics for About $650 Million

10 mrt 2026, 11:19 UTC

Acquisities, Fusies, Overnames

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 feb 2026, 12:43 UTC

Winsten

Medtronic 3Q Profit Falls Despite Higher Revenue

20 mei 2026, 13:15 UTC

Acquisities, Fusies, Overnames

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20 mei 2026, 13:15 UTC

Acquisities, Fusies, Overnames

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22 apr 2026, 11:27 UTC

Winsten

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 apr 2026, 11:50 UTC

Acquisities, Fusies, Overnames

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 mrt 2026, 20:59 UTC

Winsten

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 mrt 2026, 10:46 UTC

Acquisities, Fusies, Overnames

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 mrt 2026, 10:46 UTC

Acquisities, Fusies, Overnames

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 mrt 2026, 10:45 UTC

Acquisities, Fusies, Overnames

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 mrt 2026, 10:45 UTC

Acquisities, Fusies, Overnames

Medtronic to Acquire Scientia Vascular >MDT

17 feb 2026, 21:21 UTC

Winsten

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 feb 2026, 18:11 UTC

Winsten

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 14:48 UTC

Winsten

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 13:00 UTC

Winsten

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 12:05 UTC

Winsten

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 11:47 UTC

Winsten

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17 feb 2026, 11:47 UTC

Winsten

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17 feb 2026, 11:46 UTC

Winsten

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17 feb 2026, 11:46 UTC

Winsten

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17 feb 2026, 11:46 UTC

Winsten

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Adj EPS $1.36 >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Sales $9.02B >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Diabetes Rev $796M >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17 feb 2026, 11:45 UTC

Winsten

Medtronic 3Q Net $1.14B >MDT

Peer Vergelijking

Prijswijziging

Medtronic PLC Prognose

Koersdoel

By TipRanks

33.44% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 104.88 USD 33.44%

Hoogste 120 USD

Laagste 84 USD

Gebaseerd op 18 Wall Street-analisten die 12-maands prijsdoelen bieden voor Medtronic PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

18 ratings

11

Buy

7

Hold

0

Sell

Gebaseerd op 18 analisten die aandelenratings hebben gegeven aan Medtronic PLC - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

60 / 345 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,066.82

JNJ

Johnson and Johnson

234.57

ABBV

AbbVie Inc

216.12

UNH

UnitedHealth Group Inc

388.17

AZN

AstraZeneca PLC

187.25

Live chat